Recent Events & Catalysts
Adaptive Biotechnologies Corporation (ADPT) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
Piper Sandler Maintains Overweight on Adaptive Biotechnologies, Raises Price Target to $27.5
Benzinga · 7d ago
Adaptive Biotechnologies: The MRD Separation Creates A Pure-Play Compounder
SeekingAlpha · 11d ago
Morgan Stanley Maintains Equal-Weight on Adaptive Biotechnologies, Raises Price Target to $22
Benzinga · 12d ago
TD Cowen Maintains Buy on Adaptive Biotechnologies, Raises Price Target to $28
Benzinga · 12d ago
Guggenheim Maintains Buy on Adaptive Biotechnologies, Raises Price Target to $25
Benzinga · 12d ago
Adaptive Biotechnologies Corporation 2026 Q2 - Results - Earnings Call Presentation
SeekingAlpha · 12d ago
BTIG Maintains Buy on Adaptive Biotechnologies, Raises Price Target to $25
Benzinga · 12d ago
Adaptive Biotechnologies Corporation (ADPT) Q2 2026 Earnings Call Transcript
SeekingAlpha · 12d ago
SEC Filings (90 days)
Results of operations (earnings release), Departure/appointment of directors or officers, Financial statements and exhibits
Filed 2026-07-29 · 13d ago
Entry into a material agreement, Termination of a material agreement, Creation of a direct financial obligation (new debt), Unregistered sales of equity securities, Other events, Financial statements and exhibits
Filed 2026-06-22 · 50d ago
Other events, Financial statements and exhibits
Filed 2026-06-15 · 57d ago
Submission of matters to a vote of security holders
Filed 2026-06-09 · 63d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.